ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,701Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 192

$607K Total Retail Price of All Prescriptions

Rank: 1 out of 192

182 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alaska
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 182 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

29% of this provider’s 182 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 3,461 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alaska
HYDROCODONE-ACETAMINOPHEN 262 130 S3 1 6
LEVOTHYROXINE SODIUM 232 176 2 5
MORPHINE SULFATE ER 216 65 S2 3 30
OXYCODONE HCL 181 47 S2 4 20
LISINOPRIL 178 116 5 1
SIMVASTATIN 158 121 6 2
FUROSEMIDE 147 111 7 7
OMEPRAZOLE 146 90 8 3
POTASSIUM CHLORIDE 131 55 9 22
MORPHINE SULFATE 123 33 S2 10 98
NEXIUM 105 41 11 13
METOPROLOL SUCCINATE 104 75 12 12
GABAPENTIN 93 0 13 10
CYCLOBENZAPRINE HCL 89 28 R 14 53
LOSARTAN POTASSIUM 85 65 15 19
PANTOPRAZOLE SODIUM 81 29 16 33
AMLODIPINE BESYLATE 81 66 16 4
PREDNISONE 80 56 18 121
ZOLPIDEM TARTRATE 80 34 18 31
ADVAIR DISKUS 78 55 20 57
VENTOLIN HFA 77 34 21 81
ATENOLOL 75 45 22 11
PROAIR HFA 74 35 23 46
RANITIDINE HCL 68 28 24 15
CITALOPRAM HBR 66 57 25 21
SPIRIVA 63 40 26 124
PLAVIX 62 25 27 108
ALLOPURINOL 58 30 28 41
ISOSORBIDE MONONITRATE ER 55 22 29 60
CLOPIDOGREL 52 34 30 95
METFORMIN HCL ER 52 26 30 65
ATORVASTATIN CALCIUM 52 28 30 14
TRAZODONE HCL 51 11 33 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.